2023Q1营收归零,继续亏损,目前看不到投资价值。查看全文
AcelRx制药(ACRX)2023-05-11 05:06
$AcelRx制药(ACRX)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001437749-23-013658 Act: 34 Size: 5 MB 网页链接查看全文
AcelRx制药(ACRX)2023-05-11 04:18
$AcelRx制药(ACRX)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001437749-23-013597 Act: 34 Size: 263 KB 网页链接查看全文
AcelRx制药(ACRX)2023-04-29 04:12
$AcelRx制药(ACRX)$ 8-K Current report, item 3.01 Accession Number: 0001437749-23-011613 Act: 34 Size: 154 KB 网页链接查看全文
AcelRx制药(ACRX)2023-05-01 18:27
$AcelRx制药(ACRX)$ 10-K/A [Amend] Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-23-011719 Act: 34 Size: 1 MB 网页链接查看全文
逍遥投资派2023-05-21 00:04
$AcelRx制药(ACRX)$ 2020年营收达到顶点后连续大幅下滑两年,营业利润连续亏损5年,净利润受其他非经营收入影响2022年一度扭亏。
2023Q1营收归零,继续亏损,目前看不到投资价值。查看全文
美股律师郝俊波2021-06-09 17:18
$AcelRx制药(ACRX)$ 【AcelRx Pharmaceuticals Inc(ACRX)证券诉讼信息 】
AcelRx Pharmaceuticals Inc(ACRX)因证券欺诈案已经于近日被投资者诉至法院。在目前的诉讼中投资者指控该公司在2020年3月17日至2021年2月12日期间就公司的业务、运营及合规问题进行虚假陈述,未向投资者披露以下重大不...查看全文
$AcelRx制药(ACRX)$ 8-K Current report, items 5.03, 7.01, and 9.01 Accession Number: 0001437749-24-000938 Act: 34 Size: 395 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058578 Size: 5 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058487 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058489 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058481 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058486 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058474 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058477 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-23-058479 Size: 7 KB 网页链接
$AcelRx制药(ACRX)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-23-003509 Act: 33 Size: 1 KB 网页链接